Cargando…

Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population

IMPORTANCE: Direct costs of substance use disorders (SUDs) in the United States are incurred primarily among the working-age population. Quantifying the medical cost of SUDs in the employer-sponsored insurance (ESI) population can improve understanding of how SUDs are affecting workplaces and inform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mengyao, Peterson, Cora, Xu, Likang, Mikosz, Christina A., Luo, Feijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972180/ https://www.ncbi.nlm.nih.gov/pubmed/36692881 http://dx.doi.org/10.1001/jamanetworkopen.2022.52378

Ejemplares similares

Assessment of Annual Cost of Substance Use Disorder in US Hospitals
por: Peterson, Cora, et al.
Publicado: (2021)

Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
por: Mikosz, Christina A., et al.
Publicado: (2020)

Utilization and Cost of an Employer-Sponsored Comprehensive Primary Care Delivery Model
por: Basu, Sanjay, et al.
Publicado: (2020)

Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population
por: Mostaghimi, Arash, et al.
Publicado: (2023)

Variability in Prices Paid for Hemodialysis by Employer-Sponsored Insurance in the US From 2012 to 2019
por: League, Riley J., et al.
Publicado: (2022)

Comparison of Prices for Commonly Administered Drugs in Employer-Sponsored Insurance Relative to Medicare
por: Chang, Jessica Y., et al.
Publicado: (2023)

Relationship Between Adherence to Antihypertensive Medication Regimen and Out-of-Pocket Costs Among People Aged 35 to 64 With Employer-Sponsored Health Insurance
por: Baker-Goering, Madeleine M., et al.
Publicado: (2019)

Sources of Geographic Variation in Health Care Spending Among Individuals With Employer Sponsored Insurance
por: Johnson, William C., et al.
Publicado: (2020)

Diagnosed Prevalence and Incidence of Vitiligo in the United States: Analysis of Employer-Sponsored Insurance Claims
por: Ray, Markqayne, et al.
Publicado: (2023)

Trends in Enrollment in Employer-Sponsored Health Insurance in the US Before and During the COVID-19 Pandemic, January 2019 to June 2021
por: Parikh, Ravi B., et al.
Publicado: (2022)

Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic
por: Cantor, Jonathan, et al.
Publicado: (2021)

Cost of Public Health Insurance for US-Born and Immigrant Adults
por: Kaushal, Neeraj, et al.
Publicado: (2023)

State-Level Economic Costs of Fatal Injuries — United States, 2019
por: Peterson, Cora, et al.
Publicado: (2021)

Employer and Plan Sponsor Views on Pharmacy Reimbursement
por: Stull, Michael, et al.
Publicado: (2020)

A Substance Use Cost Calculator for US Employers With an Emphasis on Prescription Pain Medication Misuse
por: Goplerud, Eric, et al.
Publicado: (2017)

Preventing Financial Strain for Low- and Moderate-Income Adults: a Comparison of Medicaid, Marketplace, and Employer-Sponsored Insurance
por: Saluja, Sonali, et al.
Publicado: (2021)

State-Level Economic Costs of Opioid Use Disorder and Fatal Opioid Overdose — United States, 2017
por: Luo, Feijun, et al.
Publicado: (2021)

Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits
por: Morrow, Richard L, et al.
Publicado: (2019)

Earnings of Employed and Self-employed US Health Care Professionals, 2001 to 2015
por: Nasseh, Kamyar, et al.
Publicado: (2018)

Genetic testing and employer‐sponsored wellness programs: An overview of current vendors, products, and practices
por: McDonald, Whitney S., et al.
Publicado: (2020)

Access to Care, Cost of Care, and Satisfaction With Care Among Adults With Private and Public Health Insurance in the US
por: Wray, Charlie M., et al.
Publicado: (2021)

Adherence to dipeptidyl peptidase‐4 inhibitor therapy among type 2 diabetes patients with employer‐sponsored health insurance in Japan
por: Kurtyka, Karen, et al.
Publicado: (2016)

The Effectiveness of a Proactive, Three-Level Strategy to Identify People With Prediabetes in a Large Workforce With Employer-Sponsored Health Insurance
por: Herman, William H., et al.
Publicado: (2021)

Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses
por: Grabowski, David C., et al.
Publicado: (2023)

Characteristics of Physicians Excluded From US Medicare and State Public Insurance Programs for Fraud, Health Crimes, or Unlawful Prescribing of Controlled Substances
por: Chen, Alice, et al.
Publicado: (2018)

Vaping in the Workplace: Implications for Employer-Sponsored Tobacco Cessation Programs
por: Graham, Amanda L., et al.
Publicado: (2020)

The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
por: Akpinar, Ilke, et al.
Publicado: (2019)

Health-related employer support, recurring pain, and direct insurance costs for a self-insured employer
por: Williams, Jessica AR
Publicado: (2015)

Assessment of Duplicate Publication of Chinese-Sponsored Randomized Clinical Trials
por: Jia, Yuanxi, et al.
Publicado: (2020)

Return on Investment: Medical Savings of an Employer‐Sponsored Digital Intensive Lifestyle Intervention for Weight Loss
por: Horstman, Cecelia M., et al.
Publicado: (2021)

In-Person and Telehealth Ambulatory Contacts and Costs in a Large US Insured Cohort Before and During the COVID-19 Pandemic
por: Weiner, Jonathan P., et al.
Publicado: (2021)

ENTERING MEDICARE ADVANTAGE FROM EMPLOYER-SPONSORED PLANS: CHANGE IN OUT-OF-POCKET COSTS AND UTILIZATION AT AGE 65
por: Hames, Alexandra Glynn, et al.
Publicado: (2022)

Health Insurance and Differences in Infant Mortality Rates in the US
por: Johnson, Desalyn L., et al.
Publicado: (2023)

Substance Use Disorder Program Availability in Safety-Net and Non–Safety-Net Hospitals in the US
por: Chang, Ji E., et al.
Publicado: (2023)

Breadth and Exclusivity of Hospital and Physician Networks in US Insurance Markets
por: Graves, John A., et al.
Publicado: (2020)

Assessment of Dentist Participation in Public Insurance Programs for Children in the US
por: Serban, Nicoleta, et al.
Publicado: (2022)

Assessment of Language and Indexing Biases Among Chinese-Sponsored Randomized Clinical Trials
por: Jia, Yuanxi, et al.
Publicado: (2020)

Assessment of Perceptions of Mental Health vs Medical Health Plan Networks Among US Adults With Private Insurance
por: Busch, Susan H., et al.
Publicado: (2021)

Association of National Expansion of Insurance Coverage of Medically Tailored Meals With Estimated Hospitalizations and Health Care Expenditures in the US
por: Hager, Kurt, et al.
Publicado: (2022)

Vital Signs: Health Burden and Medical Costs of Nonfatal Injuries to Motor Vehicle Occupants — United States, 2012
por: Bergen, Gwen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0gnvtn2eekkpqd6ruc5v2hnf8m